Cryo-Cell International (NYSEAMERICAN:CCEL) Announces Earnings Results

Cryo-Cell International (NYSEAMERICAN:CCEL) posted its quarterly earnings results on Tuesday. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.11, Yahoo Finance reports. Cryo-Cell International had a negative net margin of 29.38% and a negative return on equity of 49.94%. The business had revenue of $8.07 million during the quarter.

Cryo-Cell International Stock Performance

CCEL stock opened at $6.25 on Thursday. The stock has a market capitalization of $50.38 million, a price-to-earnings ratio of -5.63 and a beta of 0.45. Cryo-Cell International has a 12-month low of $3.67 and a 12-month high of $9.50.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.